+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sulfasalazine"

Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027

  • Report
  • July 2023
  • 218 Pages
  • Global
From
Sulfasalazine Tablet Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Sulfasalazine Tablet Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

  • Report
  • April 2023
  • 93 Pages
  • Global
From
Loading Indicator

Sulfasalazine is a drug used to treat immune disorders, such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It works by reducing inflammation and suppressing the immune system. It is usually taken orally, but can also be administered intravenously. Side effects of sulfasalazine include nausea, vomiting, and abdominal pain. Sulfasalazine is a generic drug, meaning it is available in many different forms and from many different manufacturers. It is also available in combination with other drugs, such as methotrexate and hydroxychloroquine. The cost of sulfasalazine varies depending on the manufacturer and form. The sulfasalazine market is highly competitive, with many different manufacturers offering their own versions of the drug. Companies in the market include Pfizer, Merck, Novartis, and Teva Pharmaceuticals. Show Less Read more